Jürke Kotthaus

Reduction of<i>N</i>ω-hydroxy-<scp>L</scp>-arginine by the mitochondrial amidoxime reducing component (mARC)

Jürke Kotthaus, Bettina Wahl, Antje Havemeyer et al. · Biochemical Journal · 2010 · 90 citations · Full text

Development of Novel Potent Orally Bioavailable Oseltamivir Derivatives Active against Resistant Influenza A

Dennis Schade, Joscha Kotthaus, Lukas Riebling et al. · Journal of Medicinal Chemistry · 2014 · 80 citations · Full text

Structure–activity relationship of novel and known inhibitors of human dimethylarginine dimethylaminohydrolase-1: Alkenyl-amidines as new leads

Jürke Kotthaus, Dennis Schade, Nikola Muschick et al. · Bioorganic & Medicinal Chemistry · 2008 · 29 citations · Full text

Structure–activity Relationship, Molecular Pharmacology, Medicinal Chemistry +13

Zanamivir Amidoxime- and N-Hydroxyguanidine-Based Prodrug Approaches to Tackle Poor Oral Bioavailability

Dennis Schade, Jürke Kotthaus, Lukas Riebling et al. · Journal of Pharmaceutical Sciences · 2015 · 28 citations

Medicinal Chemistry, Pharmaceutical Science, Pharmacology +8

Synthetic Approaches to <i>N</i>^δ-Methylated <scp>l</scp>-Arginine, <i>N</i>^ω-Hydroxy-<scp>l</scp>-arginine, <scp>l</scp>-Citrulline, and <i>N</i>^δ-Cyano-<scp>l</scp>-ornithine

Dennis Schade, Katrin Töpker-Lehmann, Jürke Kotthaus et al. · The Journal of Organic Chemistry · 2008 · 25 citations

Bioorganic Chemistry, Organic Chemistry, Chemistry +16